SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-24-030048
Filing Date
2024-03-01
Accepted
2024-03-01 17:16:18
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 tm247464-1_s3.htm S-3 409810
2 EXHIBIT 5.1 tm247464d2_ex5-1.htm EX-5.1 28344
3 EXHIBIT 23.2 tm247464d2_ex23-2.htm EX-23.2 2014
4 EX-FILING FEES tm247464d2_ex-filingfees.htm EX-FILING FEES 36769
5 GRAPHIC tm247464d2_ex5-1img01.jpg GRAPHIC 2440
6 GRAPHIC lg_vynetm-4c.jpg GRAPHIC 15328
  Complete submission text file 0001104659-24-030048.txt   503027
Mailing Address 685 ROUTE 202/206 N., SUITE 301 BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 N., SUITE 301 BRIDGEWATER NJ 08807 800-775-7936
VYNE Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-277609 | Film No.: 24711559
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)